Press

The biotech company Morphosys positions itself for further growth in the USA with an acquisition worth billions. The Bavarian pharmaceutical...

Royalty Pharma to provide tailored funding solution to enable MorphoSys’ acquisition of Constellation Pharmaceuticals Investment is anchored by...

In May, the Enlarged Board of Appeal will hear a case on the lawfulness of conducting oral proceedings by compulsory video conference in case G1/21....

Maiwald, together with other leading patent law firms, considers video conferencing without the consent of the parties to be inadmissible and has...

CureVac is currently developing a vaccine against the coronavirus, CV-nCoV. The biopharmaceutical company is expanding a broad integrated European...

Medtron AG has acquired various patents for angiographic syringes from Pérouse Médical S.A.S. in an asset deal to complement its portfolio as one of...

Royalty Pharma plc (Nasdaq: RPRX) (“Royalty Pharma”) and Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (“Dicerna”) today announced that Royalty Pharma...

Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired a royalty interest in the cabozantinib products Cabometyx and Cometriq from...

Sirion Biotech announces a collaboration and license agreement with Sanofi to develop gene therapy treatments with improved adeno-associated virus...

by Dr Marco Stief and Dr Eva Ehlich in Lawyer Monthly  Open PDF document Open external Link